Summary by Futu AI
Four Circle Pharmaceutical Holdings Group Limited (“Four Circle Pharmaceuticals”) announces that a joint venture consisting of its subsidiary Long Yue Hongda Investment Management Limited and other investors has been selected as a pre-restructuring investor in the bankruptcy restructuring project of Yizhiyuk Holdings. JIYU HOLDINGS, A SHENZHEN STOCK EXCHANGE START-LISTED COMPANY THAT OPERATES PHARMACEUTICAL AND CHEMICAL INDUSTRIES, WAS ORDERED TO INITIATE THE PRE-WEIGHTING PROCESS ON 27 NOVEMBER 2023 BY THE TUNGHUA CITY INTERMEDIATE PEOPLE'S COURT. Quadruple Pharmaceuticals said that selection in the consortium is subject to the achievement of the signing and prerequisites for the restructuring agreement. The agreement has not yet been concluded and the transaction cannot be guaranteed to be finalised. The Company reminds investors and shareholders to exercise caution when trading shares. The announcement was made on February 7, 2024 by Dr. Che Feng Sheng, Chairman and Executive Director of Four Wan Pharmaceuticals.